Form 4 for ALT Altimmune, Inc.
Accepted 2024-02-01 00:00:00 ET · period of report 2024-01-31 · accession 0001104659-24-009542 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-02-01 | 2024-01-31 | ALT | Jordt Raymond M | Chief Business Off | A - Grant | $2.69 | +5,030 | 13.7K | +58% | +$13.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, par value $0.0001 | 2024-01-31 | A | A | 5,030 | $2.69 | 13,743 | D | — | — | (F2) In accordance with the ESPP, these shares were purchased based on 85% of the opening price of the issuer's common stock on August 1, 2023. (F3) The Issuer withheld 2,494 shares to cover taxes associated with the vesting of RSU on January 1, 2024 instead of the 2,503 shares reported as withheld on the individual's Form 4 filed on January 4, 2024. The updated total is reflective of the foregoing correction. |